SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-341227
Filing Date
2018-12-03
Accepted
2018-12-03 17:18:55
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d660677ds3.htm S-3 447527
2 EX-1.2 d660677dex12.htm EX-1.2 185336
3 EX-4.7 d660677dex47.htm EX-4.7 334973
4 EX-4.8 d660677dex48.htm EX-4.8 340483
5 EX-5.1 d660677dex51.htm EX-5.1 38800
6 EX-23.1 d660677dex231.htm EX-23.1 1543
7 GRAPHIC g660677g47k03.jpg GRAPHIC 40629
8 GRAPHIC g660677g51l55.jpg GRAPHIC 3170
9 GRAPHIC g660677g74n06.jpg GRAPHIC 1757
  Complete submission text file 0001193125-18-341227.txt   1412865
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-228661 | Film No.: 181214752
SIC: 2834 Pharmaceutical Preparations